DNMTs’ inhibitor 5-Aza-CdR could suppress ccRCC cell growth and induce KLF5 expression, and KLF5 mediated 5-Aza-CdR-induced growth inhibition. Here, KLF5 is linked to nonpapillary renal cell carcinoma.